FibroBiologics announced that IP Australia accepted their patent application for using cannabidiol combined with fibroblast-based cell therapy to treat degenerative disc disease. This approach aims to regenerate damaged spinal discs by protecting disc cells and enhancing fibroblast activity, addressing a major cause of chronic back and neck pain. The patent strengthens FibroBiologics' position in developing innovative treatments for disc degeneration, potentially offering a new option beyond current symptom-focused therapies. The company continues to develop fibroblast-based therapies for various chronic diseases.
Berkshire Hathaway has allocated 29.7% of its $356 billion investment portfolio to just two artificial intelligence stocks. This significant concentration underscores the growing confidence and interest in AI technologies as key drivers of future gro...
CLPS Incorporation completed an AI-driven modernization of a 30-year-old mortgage loan system for a major international bank, reducing the project time from an estimated five years with 80 developers to just 16 months with 20 developers. The AI tool,...
Sitka Gold Corp. has finalized its acquisition of the Clear Creek Property, completing its 100% ownership of the 447-square-kilometre RC Gold Project in Yukon. This property includes key deposits like Rhosgobel and targets currently under active dril...
Ramaco Resources announced new appointments in its Administration and Legal Departments, with Evan H. Jenkins taking on the role of Chief Administrative Officer overseeing key internal operations. Tyler Adkins was promoted to General Counsel, and Tyl...
Gorilla Technology Group Inc. will announce its financial results for the quarter and six months ended June 30, 2026, on August 31, 2026. The company, specializing in AI-driven security and IoT solutions, will host a live conference call to discuss t...
